Latest Advances

  • Condition: Syndrome of Inappropriate Antidiuresis (SIAD)
  • Journal: Journal of the American Society of Nephrology : JASN
  • Treatment Used: Empagliflozin
  • Number of Patients: 87
  • Published —
This trial evaluated the use of empagliflozin to treat patients with syndrome of inappropriate antidiuresis (SIAD).
  • Condition: Type 2 diabetes
  • Journal: Diabetes & vascular disease research
  • Treatment Used: Ertugliflozin alone or with other antihyperglycaemic agents
  • Number of Patients: 1544
  • Published —
The study compared the outcomes of ertugliflozin alone or with other antihyperglycaemic agents for patients with type 2 diabetes.
Showing 1-2 of 2